Literature DB >> 21333984

Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study.

Ashalatha Ganesh1, Nishant Chakravorty, Rashmi Mukherjee, Sourendrakanta Goswami, Koel Chaudhury, Baidyanath Chakravarty.   

Abstract

OBJECTIVE: To compare the efficacy of oral dydrogesterone with that of micronized vaginal P gel and micronized P capsule for luteal supplementation.
DESIGN: Prospective, randomized clinical study.
SETTING: Institute of Reproductive Medicine, Kolkata, India. PATIENT(S): A total of 1,373 infertile women undergoing IVF participated. INTERVENTION(S): Micronized P gel, P capsule, and oral dydrogesterone were administered for luteal support and compared. MAIN OUTCOME MEASURE(S): Demographic profile and pregnancy and miscarriage rates. RESULT(S): The overall pregnancy rate and miscarriage rate were comparable among the three groups. CONCLUSION(S): Oral dydrogesterone seems to be a promising drug for luteal support in woman undergoing IVF.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21333984     DOI: 10.1016/j.fertnstert.2011.01.148

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

Review 1.  Progesterone and the luteal phase: a requisite to reproduction.

Authors:  Tolga B Mesen; Steven L Young
Journal:  Obstet Gynecol Clin North Am       Date:  2015-01-05       Impact factor: 2.844

Review 2.  Luteal phase support for assisted reproduction cycles.

Authors:  Michelle van der Linden; Karen Buckingham; Cindy Farquhar; Jan A M Kremer; Mostafa Metwally
Journal:  Cochrane Database Syst Rev       Date:  2015-07-07

3.  Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques.

Authors:  Ravichandran Nadarajah; Hemashree Rajesh; Ker Yi Wong; Fazlin Faisal; Su Ling Yu
Journal:  Singapore Med J       Date:  2016-04-19       Impact factor: 1.858

4.  Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial.

Authors:  Saghar Salehpour; Maryam Tamimi; Nasrin Saharkhiz
Journal:  Iran J Reprod Med       Date:  2013-11

5.  Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.

Authors:  Xiuxian Zhu; Xiaole Zhang; Yonglun Fu
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.

Authors:  Herman Tournaye; Gennady T Sukhikh; Elke Kahler; Georg Griesinger
Journal:  Hum Reprod       Date:  2017-05-01       Impact factor: 6.918

7.  Comparable Outcomes Using Oral Dydrogesterone Vs. Micronized Vaginal Progesterone in Frozen Embryo Transfer: a Retrospective Cohort Study.

Authors:  Yuval Atzmon; Nardin Aslih; Daniela Estrada; Asaf Bilgory; Adrian Ellenbogen; Einat Shalom-Paz
Journal:  Reprod Sci       Date:  2020-11-02       Impact factor: 3.060

8.  Early-Pregnancy Dydrogesterone Supplementation Mimicking Luteal-Phase Support in ART Patients Did Not Provoke Major Reproductive Disorders in Pregnant Mice and Their Progeny.

Authors:  Laura Jeschke; Clarisa Guillermina Santamaria; Nicole Meyer; Ana Claudia Zenclussen; Julia Bartley; Anne Schumacher
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

9.  A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization.

Authors:  Valerie L Baker; Christopher A Jones; Kevin Doody; Russell Foulk; Bill Yee; G David Adamson; Barbara Cometti; Gary DeVane; Gary Hubert; Silvia Trevisan; Fred Hoehler; Clarence Jones; Michael Soules
Journal:  Hum Reprod       Date:  2014-08-06       Impact factor: 6.918

10.  Comparison of oral dydrogesterone with vaginal progesteronefor luteal support in IUI cycles: a randomized clinical trial.

Authors:  Donya Khosravi; Robabeh Taheripanah; Anahita Taheripanah; Vahid Tarighat Monfared; Seyed-Mostafa Hosseini-Zijoud
Journal:  Iran J Reprod Med       Date:  2015-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.